Tenosynovitis
9
1
1
5
Key Insights
Highlights
Success Rate
71% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 54/100
22.2%
2 terminated out of 9 trials
71.4%
-15.1% vs benchmark
33%
3 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (9)
Tenosynovitis in Polyarticular and Oligoarticular Juvenile Idiopathic Arthritis
Mobilization With Movement Versus Joint-Specific Manipulation in De Quervain's Tenosynovitis
The Treatment of Purulent Flexor Tenosynovitis
Embo Registry; National Registry for Artery Embolization
Corticosteroid(CS) + Lido or Corticosteroid(CS) Alone
Dexamethasone Versus Ketorolac Injection for the Treatment of Local Inflammatory Hand and Upper Extremity Disorders
Comparison of the Efficacy of Corticosteroid Injection and ESWT in Patients With CTS
Anesthesia Tumescent for Surgical Management of Tenosynovitis.
The Natural History of Congenital Trigger Thumbs